• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; INTRA- AORTIC BALLOOON PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL INC. REDIGUARD IAB: 8FR 40CC; INTRA- AORTIC BALLOOON PRODUCTS Back to Search Results
Catalog Number IAB-S840C
Device Problem Difficult to Insert (1316)
Patient Problem Heart Failure (2206)
Event Date 05/31/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
See manufacture report number 1219856-2016-00142 ((b)(4)) for the first report.It was reported that the event involved a 164cm in height patient.While in the (icu) intensive care unit the (iab) intra-aortic balloon catheter was prepped, the second sheath was inserted into the patient's left femoral artery.When advancing iab catheter into the sheath, the clinician felt resistance.Therefore, the iab catheter with sheath was withdrawn.An (b)(4) kit was opened, prepped and inserted into the patient's left femoral artery successfully.There was no reported patient death injury or complications.There was a delay / interruption in iabp therapy however no harm to the patient was reported.The patient outcome is listed as: "keep observation".On 06/06/2016 additional information was received.The iab was prepped per the ifu.The iab membrane did not begin to unwrap prematurely prior to insertion.The md did not use the same swg.
 
Manufacturer Narrative
Qn#(b)(4).The serial number ((b)(4)) reported on the complaint report does not match the serial number on the returned sample.However, the customer pictures show the iab sample with a serial number of (b)(4).The serial number of the returned sample is (b)(4).Returned for evaluation was a 40cc 8.0fr rediguard iab with original packaging.The original packaging upc label did not match the returned sample.The sample was returned in an insertion kit tray packaging.Upon return, dried blood was noted on the exterior of the bladder, outer lumen and bifurcate.The hemostasis cuff was connected to the cathgard.The one-way valve was tethered to the short driveline tubing.The bladder was fully unwrapped.The bladder thickness was measured at six points with measurements within specification.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve and it held for at least 1 minute and then 30 seconds five separate times.The iab was submerged in water and leak tested.No holes or leaks were detected.Full inflation was achieved.The unit passed leak test.See other remarks section.Other remarks: a lab inventory 0.025in guidewire was back loaded through iab distal tip.No resistance was noted; the guidewire was able to advance through the central lumen.No blood or debris was noted.The guidewire was front loaded through the iab luer.No resistance was noted; the guidewire was able to advance through the central lumen.No blood or debris was noted.The catheter was aspirated and flushed using a 60cc lab-inventory syringe.No abnormalities or debris were noted.Conclusion: the reported complaint of insertion difficulty is not confirmed.The iab passed functional testing.No sheath was returned for evaluation.The root cause of the complaint is undetermined.
 
Event Description
See manufacture report number 1219856-2016-00142 (tc1900046029) for the first report.It was reported that the event involved a 164cm in height patient.While in the (icu) intensive care unit the (iab) intra-aortic balloon catheter was prepped, the second sheath was inserted into the patient's left femoral artery.When advancing iab catheter into the sheath, the clinician felt resistance.Therefore, the iab catheter with sheath was withdrawn.An iab-06840-u kit was opened, prepped and inserted into the patient's left femoral artery successfully.There was no reported patient death injury or complications.There was a delay / interruption in iabp therapy however no harm to the patient was reported.The patient outcome is listed as: "keep observation".On 06/06/2016 additional information was received.The iab was prepped per the ifu.The iab membrane did not begin to unwrap prematurely prior to insertion.The md did not use the same swg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Type of Device
INTRA- AORTIC BALLOOON PRODUCTS
Manufacturer (Section D)
ARROW INTERNATIONAL INC.
reading PA
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
9 plymouth street
everett MA 02149
Manufacturer Contact
anne rosenberger
2400 bernville road
reading, PA 19605
6104783117
MDR Report Key5763112
MDR Text Key48630743
Report Number1219856-2016-00143
Device Sequence Number1
Product Code DSP
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
K981660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2017
Device Catalogue NumberIAB-S840C
Device Lot Number18F15G0018
Other Device ID Number00801902002679
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/08/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/30/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received07/29/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/21/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age68 YR
Patient Weight45
-
-